AgeX Therapeutics Inc.

AMEX: AGE · Real-Time Price · USD
11.10
-1.50 (-11.90%)
At close: Mar 26, 2024, 8:59 PM

AgeX Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
56K 142K 34K 144K
Cost of Revenue
n/a 171K 13K 19K
Gross Profit
n/a -29K 21K 125K
Operating Income
-17.05M -9.96M -6.97M -8.04M
Interest Income
n/a n/a 3.33M 1.1M
Pretax Income
-11.14M -14.81M -10.52M -8.58M
Net Income
-11.14M -14.8M -10.67M -10.22M
Selling & General & Admin
9.62M 9.33M 5.97M 6.71M
Research & Development
7.48M 603K 1.02M 1.46M
Other Expenses
n/a 11K 13K n/a
Operating Expenses
17.1M 9.93M 7M 8.16M
Interest Expense
-526K 4.9M 3.33M 1.1M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 10.1M 7.01M 8.18M
Income Tax Expense
n/a -8K 152K 1.64M
Shares Outstanding (Basic)
7.36M 1.08M 1.08M 1.08M
Shares Outstanding (Diluted)
7.36M 1.08M 1.08M 1.08M
EPS (Basic)
-1.51 -13.72 -9.89 -9.49
EPS (Diluted)
-1.51 -13.72 -9.89 -9.49
EBITDA
-17.05M -9.83M -6.97M -7.93M
EBIT
n/a -9.84M -7.19M -7.49M
Depreciation & Amortization
n/a 131K 145K 579K